Elutia (ELUT) Total Current Liabilities (2019 - 2026)
Elutia (ELUT) reported Total Current Liabilities of $23.7 million for Q1 2026, down 35.62% on a YoY basis from $36.9 million in Q1 2025, and down 5.62% sequentially from $25.1 million in Q4 2025.
Elutia (ELUT) Total Current Liabilities (2019 - 2026) Analysis & Trends
Elutia (ELUT) has 8 years of Total Current Liabilities data on file, last reported at $23.7 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities fell 35.62% year-over-year to $23.7 million; the trailing twelve-month figure through Mar 2026 stood at $23.7 million (down 35.62% YoY), and the FY2025 full-year result was $25.1 million, down 33.49% from the prior year.
- Total Current Liabilities fell to $23.7 million in Q1 2026, from $25.1 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $44.7 million in Q3 2023 to a low of $23.7 million in Q1 2026.
- A 5-year average of $37.5 million and a median of $39.7 million in 2024 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities soared 78.45% in 2022 and sank 35.62% in 2026, its largest moves.
- Tracing ELUT's Total Current Liabilities over 5 years: stood at $42.6 million in 2022, then advanced by 0.99% to $43.0 million in 2023, then fell by 12.18% to $37.8 million in 2024, then slumped by 33.49% to $25.1 million in 2025, then declined by 5.62% to $23.7 million in 2026.
- Business Quant data shows ELUT's Total Current Liabilities at $23.7 million in Q1 2026, $25.1 million in Q4 2025, and $41.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Elutia | 39.99 Mn | 11.50 Mn | 1.80 Mn | 23.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.73 Mn |
| Dec 31, 2025 | 25.14 Mn |
| Sep 30, 2025 | 41.33 Mn |
| Jun 30, 2025 | 37.95 Mn |
| Mar 31, 2025 | 36.85 Mn |
| Dec 31, 2024 | 37.80 Mn |
| Sep 30, 2024 | 39.68 Mn |
| Jun 30, 2024 | 39.81 Mn |
| Mar 31, 2024 | 38.07 Mn |
| Dec 31, 2023 | 43.04 Mn |
| Sep 30, 2023 | 44.74 Mn |
| Jun 30, 2023 | 42.87 Mn |
| Mar 31, 2023 | 41.42 Mn |
| Dec 31, 2022 | 42.62 Mn |
| Sep 30, 2022 | 40.17 Mn |
| Jun 30, 2022 | 34.75 Mn |
| Mar 31, 2022 | 27.32 Mn |
| Dec 31, 2021 | 26.00 Mn |
| Sep 30, 2021 | 22.51 Mn |
| Jun 30, 2021 | 23.60 Mn |